Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|August 21, 2004
The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agentsLeslie L CitromeThe Journal of Clinical Psychiatry|January 30, 2020
Medication Options and Clinical Strategies for Treating Tardive DyskinesiaLeslie L CitromeThe Journal of Clinical Psychiatry|January 19, 2018
Comparing Treatments for Tardive DyskinesiaLeslie L CitromeThe Annals of Pharmacotherapy|November 25, 2003
Relationship of atypical antipsychotics with development of diabetes mellitusLeslie L Citrome, Ari B JaffeThe Journal of Clinical Psychiatry|October 13, 2017
Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in TreatmentChristoph U Correll, John M Kane, Leslie L CitromeThe Journal of Clinical Psychiatry|May 16, 2019
Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient FunctioningLeslie L Citrome, Roger S McIntyre, J Sloan Manning, et al.Psychiatric Services (Washington, D.C.)|July 10, 2003
Characteristics of assaultive behavior among psychiatric inpatientsKaren A Nolan, Pál Czobor, Biman B Roy, et al.Journal of Psychiatric Research|October 27, 2004
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderKaren A Nolan, Jan Volavka, Pal Czobor, et al.Journal of Psychiatric Practice|May 25, 2007
Intramuscular aripiprazole in the control of agitationGlenn W Currier, Leslie L Citrome, Dan L Zimbroff, et al.The Annals of Pharmacotherapy|September 6, 2007
Risk of treatment-emergent diabetes mellitus in patients receiving antipsychoticsLeslie L Citrome, Richard I G Holt, Woodie M Zachry, et al.Pageof 2